BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai J, Zhang XJ, Ji YX, Zhang P, She ZG, Li H. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases. Circ Res 2020;126:679-704. [PMID: 32105577 DOI: 10.1161/CIRCRESAHA.119.316337] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Rosato V, Masarone M, Aglitti A, Persico M. The diagnostic conundrum in non-alcoholic fatty liver disease. Exploration of Medicine 2020;1. [DOI: 10.37349/emed.2020.00018] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kim KM, Roh JH, Lee S, Yoon JH. Clinical implications of renin-angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease. Sci Rep 2021;11:2884. [PMID: 33536442 DOI: 10.1038/s41598-021-81959-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Huang X, Wang Z, Shen Z, Lei F, Liu YM, Chen Z, Qin JJ, Liu H, Ji YX, Zhang P, Zhang XJ, Yang J, Cai J, She ZG, Li H. Projection of global burden and risk factors for aortic aneurysm - timely warning for greater emphasis on managing blood pressure. Ann Med 2022;54:553-64. [PMID: 35139697 DOI: 10.1080/07853890.2022.2034932] [Reference Citation Analysis]
4 Bian H, Liu YM, Chen ZN. New avenues for NASH therapy by targeting ACC. Cell Metab 2022;34:191-3. [PMID: 35108509 DOI: 10.1016/j.cmet.2022.01.001] [Reference Citation Analysis]
5 Takahashi F, Hashimoto Y, Kawano R, Kaji A, Sakai R, Kawate Y, Okamura T, Ushigome E, Kitagawa N, Majima S, Sennmaru T, Okada H, Nakanishi N, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Eating Fast Is Associated with Nonalcoholic Fatty Liver Disease in Men But Not in Women with Type 2 Diabetes: A Cross-Sectional Study. Nutrients 2020;12:E2174. [PMID: 32707957 DOI: 10.3390/nu12082174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zou Y, Zhong L, Hu C, Zhong M, Peng N, Sheng G. LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study. Lipids Health Dis 2021;20:28. [PMID: 33766067 DOI: 10.1186/s12944-021-01457-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li W, Liu J, Cai J, Zhang XJ, Zhang P, She ZG, Chen S, Li H. NAFLD as a continuous driver in the whole spectrum of vascular disease. J Mol Cell Cardiol 2021;163:118-32. [PMID: 34737121 DOI: 10.1016/j.yjmcc.2021.10.007] [Reference Citation Analysis]
8 Sheng G, Peng N, Hu C, Zhong L, Zhong M, Zou Y. The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population. Lipids Health Dis 2021;20:50. [PMID: 33993872 DOI: 10.1186/s12944-021-01479-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang X, Tan Y, Liu D, Shen H, Deng Y, Tan Y, Wang L, Zhang Y, Ma X, Zeng X, Zhang J. Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy. Eur Radiol 2022. [PMID: 35394181 DOI: 10.1007/s00330-022-08581-1] [Reference Citation Analysis]
10 Lee J, Kim HS, Cho YK, Kim EH, Lee MJ, Bae IY, Jung CH, Park JY, Kim HK, Lee WJ. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease. Sci Rep 2020;10:18323. [PMID: 33110139 DOI: 10.1038/s41598-020-75266-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Yang C, Wei J, Cao G, Cai Z. Lipid metabolism dysfunction and toxicity of BDE-47 exposure in white adipose tissue revealed by the integration of lipidomics and metabolomics. Sci Total Environ 2022;806:150350. [PMID: 34555606 DOI: 10.1016/j.scitotenv.2021.150350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ballestri S, Mantovani A, Baldelli E, Lugari S, Maurantonio M, Nascimbeni F, Marrazzo A, Romagnoli D, Targher G, Lonardo A. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics (Basel) 2021;11:98. [PMID: 33435415 DOI: 10.3390/diagnostics11010098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
13 Wang D, Day EA, Townsend LK, Djordjevic D, Jørgensen SB, Steinberg GR. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat Rev Endocrinol 2021. [PMID: 34381196 DOI: 10.1038/s41574-021-00529-7] [Reference Citation Analysis]
14 Zhang Y, Fang XM. Hepatocardiac or Cardiohepatic Interaction: From Traditional Chinese Medicine to Western Medicine. Evid Based Complement Alternat Med 2021;2021:6655335. [PMID: 33777158 DOI: 10.1155/2021/6655335] [Reference Citation Analysis]
15 Yu X, Wang Y, Lai J, Song T, Duan J. Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ir J Med Sci 2022. [PMID: 35366201 DOI: 10.1007/s11845-022-02988-x] [Reference Citation Analysis]
16 Ballestri S, Capitelli M, Fontana MC, Arioli D, Romagnoli E, Graziosi C, Lonardo A, Marietta M, Dentali F, Cioni G. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. Adv Ther 2020;37:1910-32. [PMID: 32285340 DOI: 10.1007/s12325-020-01307-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
17 Della Torre S. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front Endocrinol (Lausanne) 2020;11:572490. [PMID: 33071979 DOI: 10.3389/fendo.2020.572490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
18 Vural H, Armutcu F, Akyol O, Weiskirchen R. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clin Chim Acta 2021;523:374-9. [PMID: 34678296 DOI: 10.1016/j.cca.2021.10.018] [Reference Citation Analysis]
19 Pal P, Palui R, Ray S. Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity. World J Hepatol 2021; 13(11): 1584-1610 [PMID: 34904031 DOI: 10.4254/wjh.v13.i11.1584] [Reference Citation Analysis]
20 Venniyoor A, Al Farsi AA, Al Bahrani B. The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC). Cureus 2021;13:e17320. [PMID: 34557366 DOI: 10.7759/cureus.17320] [Reference Citation Analysis]
21 Gong H, Liu X, Cheng F. Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis. J Int Med Res 2021;49:3000605211047074. [PMID: 34590877 DOI: 10.1177/03000605211047074] [Reference Citation Analysis]
22 Zhang XJ, Cai J, Li H. Targeting ACC for NASH resolution. Trends Mol Med 2022;28:5-7. [PMID: 34844875 DOI: 10.1016/j.molmed.2021.11.002] [Reference Citation Analysis]
23 Alqahtani SA, Broering DC, Alghamdi SA, Bzeizi KI, Alhusseini N, Alabbad SI, Albenmousa A, Alfaris N, Abaalkhail F, Al-Hamoudi WK. Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease. BMC Gastroenterol 2021;21:245. [PMID: 34074270 DOI: 10.1186/s12876-021-01828-z] [Reference Citation Analysis]
24 Malakul W, Seenak P, Jumroon N, Arikit S, Kumphune S, Nernpermpisooth N. Novel Coconut Vinegar Attenuates Hepatic and Vascular Oxidative Stress in Rats Fed a High-Cholesterol Diet. Front Nutr 2022;9:835278. [DOI: 10.3389/fnut.2022.835278] [Reference Citation Analysis]
25 Yuan Y, Li K, Teng F, Wang W, Zhou B, Zhou X, Lin J, Ye X, Deng Y, Liu W, Luo S, Zhang P, Liu D, Zheng M, Li J, Lu Y, Zhang H. Leukemia inhibitory factor protects against liver steatosis in non-alcoholic fatty liver disease patients and obese mice. J Biol Chem 2022;:101946. [PMID: 35447114 DOI: 10.1016/j.jbc.2022.101946] [Reference Citation Analysis]
26 Yu T, Chen X, Zhuang W, Tian Y, Liang Z, Kong Q, Hu C, Li G, Wang Y. Nonglutaraldehyde treated porcine pericardium with good biocompatibility, reduced calcification and improved Anti-coagulation for bioprosthetic heart valve applications. Chemical Engineering Journal 2021;414:128900. [DOI: 10.1016/j.cej.2021.128900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
27 Rodriguez LA, Shiboski SC, Bradshaw PT, Fernandez A, Herrington D, Ding J, Bradley RD, Kanaya AM. Predicting Non-Alcoholic Fatty Liver Disease for Adults Using Practical Clinical Measures: Evidence from the Multi-ethnic Study of Atherosclerosis. J Gen Intern Med 2021;36:2648-55. [PMID: 33501527 DOI: 10.1007/s11606-020-06426-5] [Reference Citation Analysis]
28 Siafi E, Andrikou I, Konstantinidis D, Kakouri N, Iliakis P, Koskinas J, Koullias E, Thireos E, Tousoulis D, Thomopoulos C, Tsioufis C. Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus. J Hypertens 2021;39:2470-7. [PMID: 34738990 DOI: 10.1097/HJH.0000000000002954] [Reference Citation Analysis]
29 Zhao M, Pi Y, Zhang L, Che H. Knowledge Discovery-Based Analysis of Health Factors of Urinary Infections in Elderly Cardiology Inpatients. Journal of Healthcare Engineering 2022;2022:1-8. [DOI: 10.1155/2022/7037037] [Reference Citation Analysis]
30 Milewska EM, Szczepanek-parulska E, Marciniak M, Krygier A, Dobrowolska A, Ruchala M. Selected Organ and Endocrine Complications According to BMI and the Metabolic Category of Obesity: A Single Endocrine Center Study. Nutrients 2022;14:1307. [DOI: 10.3390/nu14061307] [Reference Citation Analysis]